Haemonetics stock edges lower to $77.59 amid overbought signals and consolidation

Traders Union
All News
Business & Wealth
Companies
Haemonetics slips 0.75% today

Highlights

HAE maintains a bullish structure, trading above all major moving averages and consolidating after a moderate pullback.
Momentum indicators remain strongly bullish, but overbought conditions suggest the current rally may pause near-term.
HAE is expected to trade sideways between $77.37 and $78.75, with a bullish breakout above resistance potentially triggering further gains.

Haemonetics shared its commitment to employee growth using the hashtags #MakeItMatter and #InternLifeAtHAE. Details are being clarified.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish structure as price holds above key moving averages

HAE is trading at $77.59, holding above its MA-20 ($75.53), MA-50 ($69.92), and MA-200 ($66.21), which highlights strong short-, medium-, and long-term bullish structure. The Ichimoku Kijun on D1 at $76.90 sits just below the market and offers immediate support. Near-term support stands at the Ichimoku Kijun ($76.90), followed by key support at MA-20 ($75.53). The nearest resistance is MA-5 ($77.12/$77.44), with a more substantial barrier at MA-10 ($76.24/$76.68).

Overbought conditions as bullish momentum meets weekly consolidation

Momentum signals remain bullish on both MACD and ADX (D1), but oscillators reveal an overbought backdrop, as seen with Stoch RSI (84.35) and CCI (144.77), while RSI is at 61.64 and trending up. BBP on D1 signals overbought conditions, confirming persistent buyer dominance. The Awesome Oscillator lends further strength to the bullish trend. HAE is trading at $77.59, down modestly from the previous weekly close of $77.86, which marks a 0.35% decline. The current price is positioned in the middle of the weekly range, and weekly volatility stands at 7.47%. Price action reflects a period of consolidation following a pullback from the week's high.

Upside probability remains strong as range-bound trade persists

For the upcoming week, HAE is expected to trade within a corridor of $77.37 to $78.75, keeping well inside the yearly range bounded by the 52-week low of $47.32 and high of $87.32. Based on W1 indicators (three "Buy" readings: RSI-W1, MACD-W1, MA-50-W1; ADX-W1 at "Neutral"), the probability of further price increase is high at 75%, while the likelihood of a decline is less. The baseline scenario envisions continued sideways movement between $77.37 and $78.75. A bullish breakout above $78.75 could open a path toward higher resistance levels in coming weeks. Conversely, a drop below $77.37 would test near-term support, with a deeper retreat only if bearish momentum intensifies.

Previously it was reported that Haemonetics was exhibiting signs of bullish momentum despite increased volatility and conflicting short-term signals. In light of current developments, investors should closely monitor for a sustained directional breakout, as confirmation of trend strength could present actionable opportunities in the coming sessions.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.